This observation, and our results of increased alt-EJ-mediated translocation formation in BMN673-treated cancer cells [39] suggests that BMN673-mediated radiosensitization can be further enhanced by targeting alt-EJ proteins other than PARP-1. The gene discussed is PARP1; the disease is cancer.